KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Ionis Pharmaceuticals (IONS) over the last 17 years, with Q3 2025 value amounting to 0.21.

  • Ionis Pharmaceuticals' Debt Ratio rose 134128.7% to 0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21, marking a year-over-year increase of 134128.7%. This contributed to the annual value of 0.02 for FY2024, which is 4001.39% down from last year.
  • As of Q3 2025, Ionis Pharmaceuticals' Debt Ratio stood at 0.21, which was up 134128.7% from 0.21 recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' Debt Ratio registered a high of 0.21 during Q2 2025, and its lowest value of 0.0 during Q1 2023.
  • Its 5-year average for Debt Ratio is 0.05, with a median of 0.03 in 2022.
  • As far as peak fluctuations go, Ionis Pharmaceuticals' Debt Ratio crashed by 8791.72% in 2023, and later soared by 134128.7% in 2025.
  • Quarter analysis of 5 years shows Ionis Pharmaceuticals' Debt Ratio stood at 0.02 in 2021, then tumbled by 73.97% to 0.01 in 2022, then surged by 357.15% to 0.03 in 2023, then crashed by 40.01% to 0.02 in 2024, then skyrocketed by 1103.28% to 0.21 in 2025.
  • Its Debt Ratio stands at 0.21 for Q3 2025, versus 0.21 for Q2 2025 and 0.02 for Q4 2024.